期刊文献+

小鼠可溶性IL-5受体α胞外区基因的克隆及原核表达 被引量:3

Cloning and Expression of Gene Encoding Extracellular Domain of Mouse Soluble IL-5 Receptor α
原文传递
导出
摘要 目的克隆并原核表达小鼠可溶性IL-5受体α(sIL-5Rα)胞外区基因。方法采用RT-PCR从BALB/c小鼠脾脏组织中分别扩增sIL-5Rα胞外区前后段基因片段,酶切后将两段基因连接,插入原核表达载体pPROEX中,构建重组表达质粒pPROEX/sIL-5Rα,转化大肠杆菌DH5α,IPTG诱导表达。采用SDS-PAGE和Western blot检测目的蛋白的表达。结果重组表达质粒经双酶切和DNA测序,证实构建正确。表达的sIL-5Rα胞外区蛋白相对分子质量约36100,表达量约占菌体总蛋白的30%,且可与兔抗小鼠sIL-5Rα单抗发生特异性免疫反应。结论已成功克隆并原核表达了小鼠sIL-5Rα胞外区基因,为进一步探讨sIL-5Rα对哮喘的治疗作用及开发新的哮喘治疗药物奠定了基础。 Objective To clone the gene encoding extracellular domain of mouse soluble IL-5 receptor α(sIL-5Rα)and ex-press in prokaryotic cells. Methods The anterior and posterior segments of gene encoding extracellular domain of sIL-5Rα were am-plified from the spleen tissues of BALB / c mice by RT-PCR,digested with restriction endonuclease,then linked and inserted into prokaryotic expression vector pPRO EX. The constructed recombinant plasmid pPRO EX / sIL-5Rα was transformed to E. coli DH5α for expression under induction of IPTG. The expressed product was identified by SDS-PAGE and Western blot. Results Both restriction analysis and DNA sequencing proved that recombinant plasmid pPRO EX / sIL-5Rα was constructed correctly. The expressed product,with a relative molecular mass of about 36 100,contained about 30% of total somatic protein and showed specific immune reaction with rabbit anti-mouse sIL-5Rα McAb. Conclusion The gene encoding extracellular domain of mouse sIL-5Rα was successfully cloned and expressed in prokaryotic cells,which laid a foundation of further study on curative effect of sIL-5Rα on asthema as well as development of novel drugs for asthema.
出处 《中国生物制品学杂志》 CAS CSCD 2009年第4期327-330,共4页 Chinese Journal of Biologicals
基金 国家自然科学基金资助项目(30770926).
关键词 可溶性IL-5受体α 胞外区 克隆 原核表达 Soluble IL-5 receptor α(sIL-5Rα) Extracellular domain Cloning Prokaryotic expression
  • 相关文献

参考文献11

  • 1Jonkers RE, Van Der Zee JS. Anti-IgE and other new immunomod- ulation-based therapies for allergic asthma. Neth J Med, 2005, 63 (4): 121-128.
  • 2Garlisi CG, Kung TF, Wang P, et al. Effects of chronic anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation. Am J Respir Cell Mol Biol, 1999, 20 (2): 248-255.
  • 3Yamagata T, Ichinose M. Agents against cytokine synthesis or receptors. Eur J Pharmacol, 2006, 533( 1-3): 289-301.
  • 4Takatsu K. Interleukin-5. Curr Opin Immunol, 1992, 4(3): 299- 306.
  • 5Krause S, Behrends J, Borowski A, et al. Blockade of interleukin- 13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alphal. Mol Immunol, 2006, 43(11 ): 1799-1807.
  • 6Ruckert R, Brandt K, Braun A, et al. Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo. J Immunol, 2005, 174(9): 5507-5515.
  • 7Garlisi CG, Kung TT, Wang P, et al. Effects of chronic anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation. Am J Respir Cell Mol Biol, 1999, 202(2): 248-255.
  • 8Inoue H, Fukuyama S, Matsumoto K, et al. Role of endogenous inhibitors of cytokine signaling in allergic asthma. CUlT Med Chem, 2007, 14(2): 181-189.
  • 9Mattes J, Foster PS. Regulation of eosinophil migration and Th2 cell function by IL-5 and eotaxin. Curr Drug Targets Inflanun Al- lergy, 2003, 2(2): 169-174.
  • 10Foster PS, Mould AW, Yang M, et al. Elemental signals regulating eosinophil accumulation in the lung. hnmunol Rev, 2001, 179: 173-181.

同被引文献39

  • 1江荣林,沈华浩,王绍斌,王萍莉,马伟斌.抗白介素5单克隆抗体抑制哮喘小鼠嗜酸性粒细胞迁移[J].基础医学与临床,2007,27(5):539-543. 被引量:6
  • 2Bhowmick B, Singh D. Novel anti-inflammatory treat ments for asthma [J]. Expert Rev Respir Med , 2008, 2 (5): 617-629.
  • 3Dente FL, Bacci E, Bartoli ML, et al. Magnitud of late asthmatic response to allergen in relation to baseline and allergen-induced sputum eosinophilia in mild asthmatic patients [J]. Ann Allergy Asthma Immunol, 2008, 100 (5): 457-462.
  • 4Scott KA, Wardlaw AJ. Eosinophilic airway disorders [J]. Semin Respir Crit Care Med, 2006, 27 (2): 128-133.
  • 5Rothenberg ME, Hogan SP. The eosinophil [J]. Annu Rev Im- munol, 2006, 24 (1): 147-174.
  • 6Yamagata T, Ichinose M. Agents against cytokine synthesis or re- ceptors [J]. Eur J Pharmaeol, 2006, 533 ( 1-3): 289-301.
  • 7Inoue H, Fukuyama S, Matsumoto K, et al. Role of endogenous inhibitors of cytokine signaling in allergic asthma [J]. Curr Med Chem, 2007, 14 (2): 181-189.
  • 8Yasunaga S, Yuyama N, Arima K, et al. The negative feedback regulation of the IL-13 signal by the IL-13 receptor alpha2 chain in bronchial epithelial cells [J]. Cytokine, 2003, 24(6): 293-303.
  • 9Yoshikawa M, Nakajima T, Tsukidater T, et al. TNF-alpba and IL-4 regulate expression of IL-13 receptor alpha 2 on human fi- broblasts [J]. Bioehem Biophys Res Commun, 2003, 312 (4): 1248-1255.
  • 10Yang M, Hogan SP, Henry PJ, et al. Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and cotaxin [J]. Am J Respir Cell Mol Biol, 2001, 25 (4): 522-530.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部